Researcher.Life Logo

Alzheimer's and Dementia: Diagnosis, Assessment and Disease Monitoring : Impact Factor & More

eISSN: 2352-8729pISSN: 2352-8729
JournalOpen Access

Key Metrics

CiteScore
7
SNIP
1
Recommended pre-submission checks
Powered by Paperpal by Editage

Alzheimer's and Dementia: Diagnosis, Assessment and Disease Monitoring Journal Specifications

Indexed in the following public directories

  • Web of Science Web of Science
  • Scopus Scopus
  • DOAJ DOAJ
  • SJR SJR
Overview
Publisher Wiley-Blackwell
Language English
Frequency Continuous publication
Article Processing ChargesUSD 2200
Publication Time8
Editorial Review ProcessBlind peer review
General Details
LanguageEnglish
Society/Institute/SponsorThe Alzheimer's Association
FrequencyContinuous publication
Publisher URLVisit website
Website URLVisit website
Publication Details
PlagiarismVisit website
Publication Time 8
Waiver PolicyVisit website
Editorial Review Detail
Editorial TeamVisit website
Review ProcessBlind peer review
Review UrlVisit website
Information for authors
Author instructionsVisit website
License typeCC BY, CC BY-NC, CC BY-NC-ND
OA statementVisit website
View less

Planning to publish in Alzheimer's and Dementia: Diagnosis, Assessment and Disease Monitoring ?

Upload your Manuscript to get

  • Degree of match
  • Common matching concepts
  • Additional journal recommendations
Free Report

Recently Published Papers in Alzheimer's and Dementia: Diagnosis, Assessment and Disease Monitoring

Identification of cognitive impairment using the Lancet Commission's risk factors and Medicare administrative data
  • 12 May 2026
  • Alzheimer's & Dementia : Diagnosis, Assessment & Disease Monitoring
Interchangeability of CSF and PET to identify Alzheimer's disease pathology
  • 12 May 2026
  • Alzheimer's & Dementia : Diagnosis, Assessment & Disease Monitoring
Application of machine learning to blood‐based biomarkers of Alzheimer's disease in Down syndrome
  • 6 Apr 2026
  • Alzheimer's & Dementia : Diagnosis, Assessment & Disease Monitoring
Incremental value of plasma biomarkers in predicting clinical decline among cognitively unimpaired older adults: Results from the A4 trial
  • 3 Apr 2026
  • Alzheimer's & Dementia : Diagnosis, Assessment & Disease Monitoring
The influence of bilingualism on the assessment and treatment of an Italian–English speaker with the logopenic variant of PPA
  • 2 Apr 2026
  • Alzheimer's & Dementia : Diagnosis, Assessment & Disease Monitoring
The relative contribution of modifiable and non-modifiable factors for determining cognition in mid-life individuals at risk for late-life Alzheimer's disease.
  • 1 Apr 2026
  • Alzheimer's & dementia (Amsterdam, Netherlands)
Identification of cognitive impairment using the Lancet Commission's risk factors and Medicare administrative data
  • 12 May 2026
  • Alzheimer's & Dementia : Diagnosis, Assessment & Disease Monitoring
Interchangeability of CSF and PET to identify Alzheimer's disease pathology
  • 12 May 2026
  • Alzheimer's & Dementia : Diagnosis, Assessment & Disease Monitoring
Application of machine learning to blood‐based biomarkers of Alzheimer's disease in Down syndrome
  • 6 Apr 2026
  • Alzheimer's & Dementia : Diagnosis, Assessment & Disease Monitoring
Incremental value of plasma biomarkers in predicting clinical decline among cognitively unimpaired older adults: Results from the A4 trial
  • 3 Apr 2026
  • Alzheimer's & Dementia : Diagnosis, Assessment & Disease Monitoring
The influence of bilingualism on the assessment and treatment of an Italian–English speaker with the logopenic variant of PPA
  • 2 Apr 2026
  • Alzheimer's & Dementia : Diagnosis, Assessment & Disease Monitoring
The relative contribution of modifiable and non-modifiable factors for determining cognition in mid-life individuals at risk for late-life Alzheimer's disease.
  • 1 Apr 2026
  • Alzheimer's & dementia (Amsterdam, Netherlands)

FAQs on Alzheimer's and Dementia: Diagnosis, Assessment and Disease Monitoring